3D Printed Muscle Tissues for Drug Discovery With Mantarray™ Platform by Curi Bio

Curi Bio, a developer of human stem cell-based platforms for drug discovery, announced the commercial launch of the Mantarray™ platform for human-relevant 3D heart and skeletal engineered muscle tissue contractility analysis. Curi’s Mantarray platform can serve for the discovery of new therapeutics by providing parallel analysis of 3D EMTs with adult human-like functional profiles of healthy and disease models.

#advertisement

How BenchSci’s ASCEND Builds a Map for Biomedical Reasoning

3D bioprinting

Image credit: luplupme iStock

It goes without saying that when the drug is developed, it needs to be tested on a highly relevant model before being approved for the clinical trials. Do we have such highly relevant models for all diseases? Obviously, no. But there are some advances which bring us closer to literally “crafting” such models by ourselves -- 3D tissue printing.

Continue reading

This content available exclusively for BPT Mebmers

BPT Membership

Topics: Biotech